Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BICO & VITK -- Ignore unavailable to you. Want to Upgrade?

To: Terry D. who wrote (2242)	1/19/1999 9:27:00 AM
From: Terry D.	Read Replies (1) \| Respond to of 2395

I suppose BUM now thinks this will make them a high flying internet power. What a laugh this company is.. Home - Yahoo! - Help [ Business \| US Market \| By Industry \| IPO \| AP \| S&P \| International \| PRNews \| BizWire ] Tuesday January 19, 8:06 am Eastern Time Company Press Release Biocontrol Subsidiary Diasense To Undergo Name Change As Part Of New Internet Marketing Plan PITTSBURGH--(BUSINESS WIRE)--Jan. 19, 1999--Biocontrol Technology Inc. (OTC BB:BICO) announced today that its subsidiary Diasense, Inc., which owns the technology and marketing rights to the Diasensor® 1000 noninvasive glucose sensor, is changing its corporate name to Diasensor.com, Inc. The change is being made as part of a new internet marketing plan that will wrap the Diasensor 1000 into an overall diabetic care program utilizing the Diasensor for internet transfer of extensive patient data stored in the device. The Company has registered the domain name www.diasensor.com where an interactive website will be developed to assist in the marketing of this innovative concept. Once the plan is finalized, further details will be released. Biocontrol Technology has its corporate offices in Pittsburgh, PA and is involved in the development and manufacture of biomedical devices and environmental products. Also located in Pittsburgh Diasense is a subsidiary of Biocontrol Technology and owns the patent, marketing and distribution rights to the sensor. Biocontrol has the exclusive rights to the research and development and manufacturing of the sensor. Further information is available at Biocontrol's Website: www.bico.com, or br calling the investor relations newsline number at 1/800-357-6204. Contact: Martin E. Janis & Company Inc., Chicago Bev Jedynak, 312/943-1100 or Biocontrol Technology Inc. Investors: Diane McQuaide, 412/429-0673 Media: Susan Taylor, 412/429-0673